Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
36.31
-0.59 (-1.60%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Tectonic Therapeutic Market Cap
Tectonic Therapeutic has a market cap or net worth of $535.01 million as of October 23, 2024. Its market cap has increased by 659.96% in one year.
Market Cap
535.01M
Enterprise Value
353.33M
1-Year Change
659.96%
Ranking
Category
Stock Price
Market Cap Chart
Since June 21, 2018, Tectonic Therapeutic's market cap has decreased from $696.20M to $535.01M, a decrease of -23.15%. That is a compound annual growth rate of -4.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2024 | 543.70M | 797.19% |
| Dec 29, 2023 | 60.60M | 94.23% |
| Dec 30, 2022 | 31.20M | -81.44% |
| Dec 31, 2021 | 168.10M | -66.92% |
| Dec 31, 2020 | 508.10M | -20.30% |
| Dec 31, 2019 | 637.50M | 59.81% |
| Dec 31, 2018 | 398.90M | -42.70% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revance Therapeutics | 554.52M |
| Third Harmonic Bio | 550.30M |
| Surmodics | 546.14M |
| SI-BONE | 541.19M |
| Arcturus Therapeutics Holdings | 535.17M |
| KalVista Pharmaceuticals | 533.71M |
| Sharecare | 531.78M |
| Cartesian Therapeutics | 529.55M |